| « Medical calendar for Sept. 3 | Zometa® Helps Prevent Bone Loss in Early Breast Cancer » |
Velcade®, Melphalan, and Prednisone Improves Survival of Patients ...
09/04/08
Velcade®, Melphalan, and Prednisone Improves Survival of Patients ...
Link: http://professional.cancerconsultants.com/oncology_main_news.aspx?id=42546
Cancer Consultants, ID - 17 hours ago Velcade has also been evaluated in combination with thalidomide or Doxil® (doxorubicin) for the treatment of refractory myeloma with promising results.
XML Feeds